ORAMED PHARMACEUTICALS INC. Effective Income Tax Rate Reconciliation, Tax Contingency, Amount
ORAMED PHARMACEUTICALS INC. (ORMP) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Amount of -$15.00 thousand for the 12-month period ending 2016-08-31, per its 10-K filed 2018-11-28.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxContingencies · last filed 2018-11-28
- ORAMED PHARMACEUTICALS INC. effective income tax rate reconciliation, tax contingency, amount for fiscal 2016 was -$15.00K.
- ORAMED PHARMACEUTICALS INC. effective income tax rate reconciliation, tax contingency, amount for fiscal 2015 was -$1.00K, a 125.00% decline from fiscal 2014.
- ORAMED PHARMACEUTICALS INC. effective income tax rate reconciliation, tax contingency, amount for fiscal 2014 was $4.00K.
- ORAMED PHARMACEUTICALS INC. effective income tax rate reconciliation, tax contingency, amount for fiscal 2013 was -$205.00K, a 327.78% decline from fiscal 2012.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount 12 month | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount 12 month as first filed | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount 125 month | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount 137 month |
|---|---|---|---|---|
| 2016-08-31 | -$15.00K 10-K · filed 2018-11-28 | |||
| 2015-08-31 | -$1.00K 10-K · filed 2017-11-29 | |||
| 2014-08-31 | $4.00K 10-K · filed 2016-11-25 | |||
| 2013-08-31 | -$205.00K 10-K · filed 2015-11-25 | -$205.06K 10-K · filed 2013-11-27 | $23.21K 10-K · filed 2013-11-27 | |
| 2012-08-31 | $90.00K 10-K · filed 2014-11-14 | $90.22K 10-K · filed 2012-12-12 | $228.27K 10-K · filed 2012-12-12 | |
| 2011-08-31 | -$23.98K 10-K · filed 2012-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |